Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories small Disadvantaged Business Spend ($M) ($M)
Abbott 2024 Global Sustainability Report
Latest, FY2024
189
Period ended Dec 31, 2024
Change on a year earlier
-13.7%
219 in FY2023
History
5 years
Since FY2020
Sources
2
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Small Disadvantaged Business Spend ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 189 | -13.7% | Abbott 2024 Global Sustainability Report ↗ |
| FY2023 | Dec 31, 2023 | 219 | +48.0% | Abbott 2024 Global Sustainability Report ↗ |
| FY2022 | Dec 31, 2022 | 148 | -28.8% | Abbott 2024 Global Sustainability Report ↗ |
| FY2021 | Dec 31, 2021 | 208 | +85.7% | Abbott 2022 Global Sustainability Report ↗ |
| FY2020 | Dec 31, 2020 | 112 | – | Abbott 2024 Global Sustainability Report ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Small Disadvantaged Business Spend ($M) ($M), annual FY2020–FY2024 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/esg-sup-sdis
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.